Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma Berko ER, Witek GM, Matkar S, … Mossé YP · Nat Commun 2023 · Nat Commun 14(1):2601 ALK and ALK Mutants Tyrosine kinase Signaling biology PhosphoSens Read the paper View on PubMed
